Company Filing History:
Years Active: 2018-2025
Title: Mark Penney: Innovator in Antibody Development
Introduction
Mark Penney is a distinguished inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 5 patents to his name, Penney's work has the potential to impact medical treatments significantly.
Latest Patents
One of Mark Penney's latest patents focuses on "Antibodies to ticagrelor and methods of use." This patent discloses antibodies and antigen-binding fragments that specifically bind to ticagrelor and its metabolites. The patent also outlines compositions that include these antibodies, nucleic acid molecules encoding them, and methods for treating patients through the administration of these antibodies. This innovative approach could lead to improved therapeutic options for patients requiring ticagrelor treatment.
Career Highlights
Mark Penney has built a reputable career in the biotechnology sector. He is currently associated with Medimmune Limited, where he continues to advance his research and development efforts. His expertise in antibody technology has positioned him as a key player in the industry.
Collaborations
Throughout his career, Mark has collaborated with notable colleagues, including Sven Nylander and Philip Newton. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Mark Penney's contributions to antibody development exemplify the spirit of innovation in biotechnology. His work not only advances scientific knowledge but also holds promise for improving patient care.